A molecularly tailored closed-loop tumor cell energy nanodepleter for cancer starvation therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Cancer, Hypoxia, and Metabolism · Nanoplatforms for cancer theranostics · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Cancer statistics, 202010.3322/caac.21590 ↗
2. Cancer metabolism: looking forward10.1038/s41568-021-00378-6 ↗
3. Impairing tumor metabolic plasticity via a stable metal-phenolic-based polymeric nanomedicine to suppress colorectal cancer.10.1002/adma.202300548 ↗
4. Tumor cell energy metabolism and its common features with yeast metabolism
5. Anti-cancer strategy targeting the energy metabolism of tumor cells surviving a low-nutrient acidic microenvironment10.1016/j.molmet.2020.101093 ↗
6. Attenuating metabolic competition of tumor cells for favoring the nutritional demand of immune cells by a branched polymeric drug delivery system10.1002/adma.202210161 ↗
7. The emerging hallmarks of cancer metabolism10.1016/j.cmet.2015.12.006 ↗
8. A mitochondria-targeting and polarity-sensitive fluorescent probe for cancer diagnosis
9. Mitochondrion-targeted supramolecular "nano-boat" simultaneously inhibiting dual energy metabolism for tumor selective and synergistic chemo-radiotherapy10.7150/thno.67543 ↗
10. Mitochondria in cancer10.15698/cst2020.06.221 ↗
11. Energy disruptors: rising stars in anticancer therapy?10.1038/oncsis.2015.46 ↗
12. Mitochondria and cancer10.1016/j.cell.2016.07.002 ↗
13. TME-triggered MnSiO(3)@Met@GOx nanosystem for ATP dual-inhibited starvation/chemodynamic synergistic therapy10.1016/j.biomaterials.2022.121682 ↗
14. Mitochondria as a target in cancer treatment10.1002/mco2.16 ↗
15. An epigenetic role of mitochondria in cancer10.3390/cells11162518 ↗
16. Mitochondrial metabolism as a target for cancer therapy10.1016/j.cmet.2020.06.019 ↗
17. Mitochondrial OXPHOS induced by RB1 deficiency in breast cancer: implications for anabolic metabolism, stemness, and metastasis10.1016/j.trecan.2017.09.002 ↗
18. Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes10.1158/0008-5472.CAN-14-1428 ↗
19. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death10.1158/0008-5472.CAN-11-3928 ↗
20. (2020). Tumor microenvironment responsive drug delivery systems10.1016/j.ajps.2019.08.003 ↗
21. Suppression of energy metabolism in cancer cells with nutrient-sensing nanodrugs10.1021/acs.nanolett.2c00356 ↗
22. The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting10.1016/j.critrevonc.2017.01.002 ↗
23. Self-engineered lipid peroxidation nano-amplifier for ferroptosis-driven antitumor therapy
24. Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models10.1016/j.cclet.2020.05.034 ↗
25. Molecularly self-fueled nano-penetrator for nonpharmaceutical treatment of thrombosis and ischemic stroke.10.1038/s41467-023-35895-5 ↗
26. Precisely engineering a dual-drug cooperative nanoassembly for proteasome inhibition-potentiated photodynamic therapy10.1016/j.cclet.2021.11.056 ↗
27. Nanovehicles for co-delivery of anticancer agents10.1016/j.drudis.2020.06.027 ↗
28. Precisely engineering a carrier-free hybrid nanoassembly for multimodal DNA damage-augmented photodynamic therapy
29. Advances in nanomedicine for cancer starvation therapy10.7150/thno.38261 ↗
30. Emerging carrier-free nanosystems based on molecular self-assembly of pure drugs for cancer therapy.10.1002/med.21669 ↗
31. A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis10.1038/s41467-018-07197-8 ↗
32. A dual functional nanoreactor for synergistic starvation and photodynamic therapy10.1021/acsami.0c01039 ↗
33. Pure photosensitizer-driven nanoassembly with core-matched PEGylation for imaging-guided photodynamic therapy10.1016/j.apsb.2021.04.005 ↗
34. Carrier-free nanodrugs for safe and effective cancer treatment10.1016/j.jconrel.2020.10.014 ↗
35. Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy10.1021/acs.nanolett.6b01632 ↗
36. Elaborately engineering of a dual-drug co-assembled nanomedicine for boosting immunogenic cell death and enhancing triple negative breast cancer treatment10.1016/j.ajps.2022.02.004 ↗
37. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
38. Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy10.1016/j.biomaterials.2020.120557 ↗
39. Emerging small molecule-engineered hybrid nanomedicines for cancer therapy10.1016/j.cej.2022.135160 ↗
40. Self-adaptive nanoassembly enabling turn-on hypoxia illumination and periphery/center closed-loop tumor eradication
41. In situ self-assembled nanomedicines for cancer treatment
42. Intramitochondrial disulfide polymerization controls cancer cell fate10.1021/acsnano.1c04015 ↗
43. Why cancer cells have a more hyperpolarised mitochondrial membrane potential and emergent prospects for therapy
44. Regulating glucose metabolism with prodrug nanoparticles for promoting photoimmunotherapy of pancreatic cancer